Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints

ANZ Journal of Surgery

Volumn 74, Issue 4, 2004, Pages 210-214

  Everts, Richard J ^a,c   Chambers, Stephen T ^a   Murdoch, David R ^b   Rothwell, Alastair G ^a   McKie, John ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

^c NELSON HOSPITAL   (New Zealand)

Author keywords

Beta haemolytic; Hip prosthesis; Infection; Knee prosthesis; Septic arthritis; Streptococci

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; RIFAMPICIN;

ALLERGY; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIMICROBIAL ACTIVITY; ARTHROPLASTY; BACTERIAL INFECTION; DEBRIDEMENT; DRAIN; EXCISION; FOLLOW UP; HIP; HUMAN; IMPLANT; KNEE; LAVAGE; LONG TERM CARE; PROSTHESIS; RELAPSE; RETROSPECTIVE STUDY; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DEVICE REMOVAL; FEMALE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS;

EID: 2442586635     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2004.02942.x     Document Type: Review

References (56)

1. Tobin EH. Prosthetic joint infections: controversies and clues. Lancet 1999; 353: 770-1.
2. Karchmer AW. Salvage of infected orthopedic devices. Clin. Inf. Dis. 1998; 27: 714-16.
3. Segreti J, Nelson JA, Trenholm GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin. Infect. Dis. 1998; 27: 711-13.
4. Segawa H, Tsukayama D, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty: a retrospective study of the treatment of eighty-one infections. J. Bone Joint Surg. 1999; 81-A: 1434-45.
5. Stein A, Bataille JF, Drancourt M et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob. Agents Chemother. 1998; 42: 3086-91.
6. Desplaces N, Acar JF. New Quinolones in the treatment of joint and bone infections. Rev. Infect. Dis 1988; 10: S179-83.
7. Freeman MAR, Sudlow RA, Casewell MW, Radcliff SS. The management of infected total knee replacements. J. Bone Joint Surg. 1985; 67-B: 764-8.
8. Perry CR, Hulsey RE, Mann FA, Miller GA, Pearson RL. Treatment of acutely infected arthroplasties with incision, drainage, and local antibiotics delivered by an implantable pump. Clin. Orthop. 1992; 281: 216-23.
9. Rand JA, Bryan RS, Morrey BF, Westholm F. Management of infected total knee arthroplasty. Clin. Orthop. 1986; 205: 75-85.
10. Morrey BF, Westholm F, Schoifet S, Rand JA, Bryan RS. Long-term results of various treatment options for infected total knee arthroplasty. Clin. Orthop. 1989; 248: 120-8.
11. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J. Bone Joint Surg. 1996; 78-A: 512-23.
12. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin. Infect. Dis 1992; 14: 1251-3.
13. Mont MA, Waldman B, Banerjee C, Pacheco IH, Hungerford DS. Multiple irrigation, debridement, and retention of components in infected total knee arthroplasty. J. Arthroplasty 1997; 12: 426-33.
14. Burkert T, Watanakunakom C. Group G streptococcus septic arthritis and osteomyelitis: report and literature review. J. Rheumatol. 1991; 18: 904-7.
15. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifamipicin for treatment of orthopedic implant-related staphylococcal infections: a randomised controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-41.
16. Brouqui P, Rousseau MC, Stein A, Drancourt M, Raoult D. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime- ciprofloxacin antibiotic combination. Antimicrob. Agents Chemother. 1995; 39: 2423-5.
17. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop. Clin. North Am. 1975; 6: 991-1003.
18. Jackson MA, Nelson JD. Etiology and medical management of acute suppurative bone and joint infections in pediatric patients. J. Ped. Orthop. 1982; 2: 313-23.
19. Cooper C, Cawley MID. Bacterial arthritis in an English health district: a 10 year review. Ann. Rheum. Dis. 1986; 45: 458-63.
20. Kristensen B, Schønheyder HC. A 13-year survey of bacteraemia due to beta haemolytic streptococci in a Danish county. J. Med. Microbiol. 1995; 43: 63-7.
21. Sundkvist T, von Essen R. Group C streptococcal infection in a prosthetic joint. South. Med. J. 2000; 95: 107.
22. Deighton C. Haemolytic streptococci and musculoskeletal sepsis in adults. Ann. Rheum. Dis. 1993; 52: 483-7.
23. Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, Wenger JD, Stephens DS. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N. Engl. J. Med. 1993; 328: 1807-11.
24. Jackson LA, Hilsdon R, Farley M et al. Risk factors for group B streptococcal disease in adults. Ann. Intern. Med. 1995; 123: 415-20.
25. Verghese A, Mireault K, Arbeit RD. Group B streptococcal bacteremia in men. Rev. Infect. Dis. 1986; 8: 912-17.
26. Rasul AT, Tsukayama D, Gustilo RB. Effect of time of onset and depth of infection on the outcome of total knee arthroplasty infections. Clin. Orthop. Rel. Res. 1991; 273: 98-104.
27. Borden LS, Gearen PF. Infected total knee arthroplasty: a protocol for management. J. Arthroplasty 1987; 2: 27-36.
28. Teeny SM, Door L, Murata G, Canaty P. Treatment of infected total knee arthroplasty: irrigation and debridement versus two stage reimplantation. J. Arthroplasty 1990; 5: 35-9.
29. Burger RR, Basch T, Hopson CN. Implant salvage in infected total knee arthroplasty. Clin. Orthop. Rel. Res. 1991; 273: 105-12.
30. Grogan TJ, Dorey F, Rollins J, Amstutz HC. Deep sepsis following total knee arthroplasty. J. Bone Joint Surg. 1986; 68-A: 226-34.
31. Nelson CL, Evarts CM, Andrish J, Marks K. Results of infected total hip replacement arthroplasty. Clin. Orthop. Rel. Res. 1980; 147: 258-61.
32. Brandt CM, Sistrunk WW, Duffy MC et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin. Infect. Dis. 1997; 24: 914-19.
33. Jacobs MA, Hungerford DS, Krackow KA, Lennox DW. Revision of septic total knee arthroplasty. Clin. Orthop. Rel. Res. 1989; 238: 159-66.
34. Hanssen AD, Trousdale RT, Osmon DR. Patient outcome with reinfection following reimplantation for the infected total knee arthroplasty. Clin. Orthop. Rel. Res. 1995; 321: 55-67.
35. Murray RP, Bourne MH, Fitzgerald RH. Metachronous infections in patients who have had more than one total joint arthroplasty. J. Bone Joint Surg. 1991; 73-A: 1469-74.
36. Kaar TK, Bogoch ER, Devlin HR. Acute metastatic infection of a revised total hip arthroplasty with oral bacteria after non-invasive dental treatment. J. Arthroplasty 2000; 15: 675-8.
37. Nadlacan LM, Hirst P. Infected total knee replacement following a dental procedure in a severe haemophiliac. Knee 2001; 8: 159-61.
38. Hyman JL, Salvati EA, Laurencin CT, Rogers DE, Maynard M, Brause BD. The arthroscopic drainage, irrigation, and debridement of late, acute total hip arthroplasty infections: average 6-year follow-up. J. Arthroplasty 1999; 14: 903-10.
39. Maniloff G, Greenwald R, Laskin R, Singer C. Delayed post-bacteremic prosthetic joint infection. Clin. Orthop. Rel. Res. 1987; 223: 194-7.
40. Ryczak M, Sands M, Brown RB, Sklar JH. Pneumococcal arthritis in a prosthetic joint. A case report and review of the literature. Clin. Orthop. Rel. Res. 1987; 224: 224-7.
41. Antti-Poika I, Santavirta S, Konttinen YT, Honkanen V. Outcome of the infected hip arthroplasty. A retrospective study of 36 patients. Acta Orthop. Scand. 1989; 60: 670-5.
42. Small CB, Slater LN, Lowy FD, Small RD, Salvati EA, Casey JI. Group B streptococcal arthritis in adults. Am. J. Med. 1984; 76: 367-75.
43. Triesenberg SN, Clark NM, Kauffman CA. Group B streptococcal prosthetic joint infection following sigmoidoscopy. Clin. Infect. Dis. 1992; 15: 374-5.
44. Bliss DG, McBride GG. Infected total knee arthroplasties. Clin. Orthop. Rel. Res. 1985; 199: 207-14.
45. Cunningham R, Walker C, Ridgway E. Prosthetic hip-joint infection associated with a penicillin-tolerant group B streptococcus. J. Infect. 1992; 25: 77-81.
46. Kleshinski J, Georgiadis GM, Duggan JM. Group C streptococcal infection in a prosthetic joint. South. Med. J. 2000; 93: 1217-20.
47. Vartian C, Lerner PI, Shales DM, Geopalakrishna KV. Infections due to Lancefield Group G streptococci. Medicine 1985; 64: 75-88.
48. Stinchfield FE, Bigliani LU, Neu HC, Goss TP, Foster CR. Late haematogenous infection of total joint replacement. J. Bone Joint Surg. 1980; 62-A: 1345-50.
49. Bradlow A, Mitchell RG, Mowat A. Group G streptococcal arthritis. Rheumatol. Rehabil. 1982; 21: 206-10.
50. Nakata MM, Silvers JH, George L. Group G streptococcal arthritis. Arch. Intern. Med. 1983; 143: 1328-30.
51. Lam K, Bayer AS. Serious infections due to Group G streptococci. Report of 15 cases with in vitro- in vivo correlations. Am. J. Med. 1983; 75: 561-70.
52. Venezio FR, Gullberg RM, Westenfelder GO, Phair JP, Cook FV. Group G streptococcal endocarditis and bacteraemia. Am. J. Med. 1986; 81: 29-34.
53. Goulet JA, Pellicci PM, Brause BD, Salvati EM. Prolonged suppression of infection in total hip arthroplasty. J. Arthroplasty 1988; 3: 109-16.
54. Wolfe SW, Figgie MP, Inglis AE, Bohn WW, Ranawat CS. Management of infection about total elbow prostheses. J. Bone Joint Surg. 1990; 72-A: 198-212.
55. Waldman BJ, Hostin E, Mont MA, Hungerford DS. Infected total knee arthroplasty treated by arthroscopic irrigation and debridement. J. Arthroplasy 2000; 15: 430-6.
56. Ivey FM, Hicks CA, Calhoun JH, Mader JT. Treatment options for infected knee arthroplasties. Rev. Infect. Dis 1990; 12: 468-78.